Novel Treatments for Neuromuscular Disorders

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). 

Spotlight

September 6, 2017 Flex Pharma Presenting at Upcoming Investor Conferences in September 2017
Read More

August 2, 2017 Flex Pharma Reports Second Quarter 2017 Financial Results
Read More